Apellis Pharmaceuticals Inc Earnings

The next earnings date for Apellis Pharmaceuticals Inc is November 10, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Apellis Pharmaceuticals Inc Earnings

Report Date	Estimated Earnings Per Share
11/10/2025	$1.60

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Apellis Pharmaceuticals Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
07/31/2025	---	$-0.33	31.25%
05/05/2025	Before Market	$-0.74	-37.04%
02/25/2025	Before Market	$-0.29	27.84%
11/05/2024	Before Market	$-0.46	-54.13%
08/01/2024	Before Market	$-0.28	12.50%
05/07/2024	Before Market	$-0.42	10.64%
02/27/2024	Before Market	$-0.73	-5.80%
11/01/2023	Before Market	$-1.17	-36.05%
07/31/2023	Before Market	$-1.02	22.73%
05/04/2023	After Market	$-1.56	-6.85%
02/21/2023	After Market	$-1.50	4.46%
11/07/2022	After Market	$-1.75	-20.69%
08/08/2022	After Market	$-1.46	-7.35%
05/04/2022	After Market	$-1.42	-7.58%
02/28/2022	After Market	$-1.61	-4.55%
11/08/2021	After Market	$-2.28	-34.12%
08/09/2021	After Market	$-2.72	-60.95%
04/28/2021	After Market	$-2.32	-43.21%
02/25/2021	After Market	$0.93	224.00%
11/02/2020	Before Market	$-1.79	-13.29%
07/30/2020	After Market	$-1.57	-17.16%
04/29/2020	After Market	$-2.29	-65.94%
02/27/2020	After Market	$-1.77	-55.26%
11/05/2019	Before Market	$-1.10	-8.91%
07/31/2019	After Market	$-1.12	-45.45%
05/07/2019	After Market	$-0.87	-29.85%
02/26/2019	After Market	$-0.65	7.14%
11/13/2018	Before Market	$-0.64	7.25%
07/31/2018	After Market	$-0.61	-29.79%
04/30/2018	After Market	$-0.43	-30.30%
03/19/2018	After Market	$-0.60	-25.00%
12/20/2017	After Market	$-1.37	-57.47%
08/30/2017	---	$-1.26	---
05/04/2017	---	$-1.07	---

More About Apellis Pharmaceuticals Inc

Website

https://apellis.com

Country

USA

Full Time Employees

705

Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. It offers EMPAVELI for the treatment of paroxysmal nocturnal hemoglobinuria; and SYFOVRE for treating geographic atrophy secondary to age-related macular degeneration and geographic atrophy (GA). The company also develops EMPAVELI to treat C3 glomerulopathy and immune complex membranoproliferative glomerulonephritis, hematopoietic stem cell transplantation-associated thrombotic microangiopathy, focal segmental glomerulosclerosis, and delayed graft function; and APL-3007, a small interfering RNA, or siRNA for the treatment of GA. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) for development and commercialization of pegcetacoplan; and a collaboration with Beam Therapeutics Inc. focused on the use of Beam's base editing technology to discover new treatments for complement-driven diseases. The company was incorporated in 2009 and is based in Waltham, Massachusetts.

“Apellis Pharmaceuticals Inc Earnings” Can Refer to the Apellis Pharmaceuticals Inc Earnings Date

Some people say “Apellis Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Apellis Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Apellis Pharmaceuticals Inc Stock on the Earnings Date

If you own Apellis Pharmaceuticals Inc stock (APLS) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Apellis Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Apellis Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Apellis Pharmaceuticals Inc Earnings

You can contact us any time if you would like to ask questions about Apellis Pharmaceuticals Inc earnings or anything else related to the stock market.